Your browser doesn't support javascript.
loading
Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts.
Zeidan, Amer M; Boddu, Prajwal C; Patnaik, Mrinal M; Bewersdorf, Jan Philipp; Stahl, Maximilian; Rampal, Raajit K; Shallis, Rory; Steensma, David P; Savona, Michael R; Sekeres, Mikkael A; Roboz, Gail J; DeAngelo, Daniel J; Schuh, Andre C; Padron, Eric; Zeidner, Joshua F; Walter, Roland B; Onida, Francesco; Fathi, Amir; DeZern, Amy; Hobbs, Gabriela; Stein, Eytan M; Vyas, Paresh; Wei, Andrew H; Bowen, David T; Montesinos, Pau; Griffiths, Elizabeth A; Verma, Amit K; Keyzner, Alla; Bar-Natan, Michal; Navada, Shyamala C; Kremyanskaya, Marina; Goldberg, Aaron D; Al-Kali, Aref; Heaney, Mark L; Nazha, Aziz; Salman, Huda; Luger, Selina; Pratz, Keith W; Konig, Heiko; Komrokji, Rami; Deininger, Michael; Cirici, Blanca Xicoy; Bhatt, Vijaya Raj; Silverman, Lewis R; Erba, Harry P; Fenaux, Pierre; Platzbecker, Uwe; Santini, Valeria; Wang, Eunice S; Tallman, Martin S.
Afiliación
  • Zeidan AM; Section of Hematology, Yale School of Medicine, Yale University, New Haven, CT, USA; Yale Comprehensive Cancer Center, Yale School of Medicine, Yale University, New Haven, CT, USA. Electronic address: amer.zeidan@yale.edu.
  • Boddu PC; Section of Hematology, Yale School of Medicine, Yale University, New Haven, CT, USA; Yale Comprehensive Cancer Center, Yale School of Medicine, Yale University, New Haven, CT, USA.
  • Patnaik MM; Department of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Bewersdorf JP; Section of Hematology, Yale School of Medicine, Yale University, New Haven, CT, USA; Yale Comprehensive Cancer Center, Yale School of Medicine, Yale University, New Haven, CT, USA.
  • Stahl M; Department of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Rampal RK; Department of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Shallis R; Section of Hematology, Yale School of Medicine, Yale University, New Haven, CT, USA; Yale Comprehensive Cancer Center, Yale School of Medicine, Yale University, New Haven, CT, USA.
  • Steensma DP; Department of Hematology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Savona MR; Department of Hematology, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
  • Sekeres MA; Leukemia Program, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA.
  • Roboz GJ; Department of Hematology and Oncology, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY, USA.
  • DeAngelo DJ; Department of Hematology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Schuh AC; Division of Medical Oncology and Hematology, University of Toronto, Toronto, ON, Canada.
  • Padron E; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA.
  • Zeidner JF; Division of Hematology and Oncology, Lineberger Comprehensive Care Center, University of North Carolina, Chapel Hill, NC, USA.
  • Walter RB; Division of Hematology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Onida F; Department of Hematology, IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.
  • Fathi A; Department of Hematology, Centre for Leukemia, Massachusetts General Hospital, Boston, MA, USA.
  • DeZern A; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA.
  • Hobbs G; Department of Hematology, Centre for Leukemia, Massachusetts General Hospital, Boston, MA, USA.
  • Stein EM; Department of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Vyas P; MRC Molecular Haematology Unit, BRC Oxford Department of Haematology, University of Oxford, Oxford, UK.
  • Wei AH; Department of Clinical Haematology, Alfred Hospital, Melbourne, VIC, Australia.
  • Bowen DT; Department of Haematology, Leeds Teaching Hospitals National Health Service Trust, Leeds, UK.
  • Montesinos P; Department of Haematology, Hospital Universitario y Politecnico La Fe, Valencia, Spain; CIBERONC, Instituto Carlos III, University of Valencia, Madrid, Spain.
  • Griffiths EA; Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Verma AK; Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY, USA.
  • Keyzner A; Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Bar-Natan M; Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Navada SC; Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Kremyanskaya M; Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Goldberg AD; Department of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Al-Kali A; Department of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Heaney ML; Department of Hematology, Herbert Irving Comprehensive Care Centre, Columbia University, New York, NY, USA.
  • Nazha A; Department of Hematology, Cleveland Clinic-Taussig Cancer Institute, Cleveland, OH, USA.
  • Salman H; Department of Internal Medicine, Stony Brook University Cancer Center, Stony Brook, NY, USA.
  • Luger S; Department of Medicine, Hematology and Oncology Division, University of Pennsylvania, Philadelphia, PA, USA.
  • Pratz KW; Department of Medicine, Hematology and Oncology Division, University of Pennsylvania, Philadelphia, PA, USA.
  • Konig H; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, Indiana University, Indianapolis, IN, USA.
  • Komrokji R; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA.
  • Deininger M; Huntsman Cancer Institute, Department of Medicine, Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT, USA.
  • Cirici BX; Clinical Haematology Department, Josep Carreras Leukaemia Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Bhatt VR; Fred and Pamela Buffett Cancer Center, Department of Oncology and Hematology, University of Nebraska Medical Center, Omaha, NE, USA.
  • Silverman LR; Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Erba HP; Duke Cancer Institute, Department of Medicine, Division of Hematologic Malignancies and Cellular Therapies, Durham, NC, USA.
  • Fenaux P; Department of Hematology, Hôpital St Louis, Assistance Publique-Hôpitaux de Paris, Paris, France; Department of Haematology, Paris University, Paris, France.
  • Platzbecker U; Department of Medicine, Division of Translational Hematology, Leipzig University Hospital, Leipzig, Germany.
  • Santini V; Department of Medicine, University of Florence Medical School, Florence, Italy.
  • Wang ES; Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Tallman MS; Department of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Lancet Haematol ; 7(8): e601-e612, 2020 Aug.
Article en En | MEDLINE | ID: mdl-32563283
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neumonía Viral / Leucemia / Control de Infecciones / Guías de Práctica Clínica como Asunto / Infecciones por Coronavirus / Betacoronavirus / Trastornos Mieloproliferativos Tipo de estudio: Clinical_trials / Guideline Aspecto: Ethics Límite: Adult / Humans Idioma: En Revista: Lancet Haematol Año: 2020 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neumonía Viral / Leucemia / Control de Infecciones / Guías de Práctica Clínica como Asunto / Infecciones por Coronavirus / Betacoronavirus / Trastornos Mieloproliferativos Tipo de estudio: Clinical_trials / Guideline Aspecto: Ethics Límite: Adult / Humans Idioma: En Revista: Lancet Haematol Año: 2020 Tipo del documento: Article Pais de publicación: Reino Unido